Epitizide
CARDIOVASCULAR SYSTEM
Also known as: epithiazide, epitizid
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Epitizide is a drug catalogued in DrugCentral. Recorded indications include Hypertensive disorder.
- Indications: Hypertensive disorder.
- ATC code: C03EA03 (Low-ceiling diuretics and potassium-sparing agents).
- Molecular formula: C10H11ClF3N3O4S3; molecular weight 425.84 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (1)
- Hypertensive disorder
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
C03EA03 | CARDIOVASCULAR SYSTEM › DIURETICS › DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION › Low-ceiling diuretics and potassium-sparing agents |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Epitizide is on its molecule page.
| Molecular formula | C10H11ClF3N3O4S3 |
|---|---|
| Molecular weight | 425.84 g/mol |
| CAS number | 1764-85-8 |
| InChIKey | RINBGYCKMGDWPY-UHFFFAOYSA-N |
| PubChem CID | 15671 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Epitizide used for?
DrugCentral lists the following indications for Epitizide: Hypertensive disorder.
What is the chemical formula of Epitizide?
Epitizide has the molecular formula C10H11ClF3N3O4S3 and a molecular weight of 425.84 g/mol.
Browse: all drugs starting with E · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 1031 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL2104605 — compound record and bioactivity
- PubChem CID 15671 — chemical identifiers
- DrugBank DB13989 — drug record
- FDA UNII 5B266B85J1 — substance identity
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.